Search research articles
Contact Us
Filters
Showing results (31-40 of 161) with videos related to
Page
of 17
Sort By:
Cancers
|
June 22, 2023
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer
Peter H J Slootbeek, Iris S H Kloots, Inge M van Oort, et al.
British Journal of Clinical Pharmacology
|
September 8, 2017
Drug-drug interaction potential in men treated with enzalutamide: Mind the gap
Guillemette Emma Benoist, Inge M van Oort, Stella Smeenk, et al.
British Journal of Clinical Pharmacology
|
August 26, 2021
The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancer
Emmy Boerrigter, Guillemette E Benoist, Joanneke K Overbeek, et al.
Cancer Chemotherapy and Pharmacology
|
September 14, 2019
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
Floor J E Lubberman, Guillemette E Benoist, Winald Gerritsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 9, 2021
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Maarten J van der Doelen, Agnes Stockhaus, Yuanjun Ma, et al.
Nature Communications
|
April 24, 2023
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, et al.
Therapeutic Advances in Medical Oncology
|
December 17, 2024
Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysis
Catharina J P Op 't Hoog, Sabien J E Bosman, Emmy Boerrigter, et al.
Non-Coding RNA
|
December 22, 2022
The Androgen Regulated lncRNA <i>NAALADL2-AS2</i> Promotes Tumor Cell Survival in Prostate Cancer
Levi Groen, Viktor Yurevych, Harshitha Ramu, et al.
Clinical Nuclear Medicine
|
November 23, 2017
223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice
Maarten J van der Doelen, Malou C P Kuppen, Marianne A Jonker, et al.
BMJ Open
|
May 19, 2021
Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the 'trials within cohorts' study ProBCI
Anke Richters, Richard P Meijer, Niven Mehra, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 161) with videos related to
Sort By:
Page
of 17
Cancers
|
June 22, 2023
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer
Peter H J Slootbeek, Iris S H Kloots, Inge M van Oort, et al.
British Journal of Clinical Pharmacology
|
September 8, 2017
Drug-drug interaction potential in men treated with enzalutamide: Mind the gap
Guillemette Emma Benoist, Inge M van Oort, Stella Smeenk, et al.
British Journal of Clinical Pharmacology
|
August 26, 2021
The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancer
Emmy Boerrigter, Guillemette E Benoist, Joanneke K Overbeek, et al.
Cancer Chemotherapy and Pharmacology
|
September 14, 2019
A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics
Floor J E Lubberman, Guillemette E Benoist, Winald Gerritsen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 9, 2021
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Maarten J van der Doelen, Agnes Stockhaus, Yuanjun Ma, et al.
Nature Communications
|
April 24, 2023
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, et al.
Therapeutic Advances in Medical Oncology
|
December 17, 2024
Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysis
Catharina J P Op 't Hoog, Sabien J E Bosman, Emmy Boerrigter, et al.
Non-Coding RNA
|
December 22, 2022
The Androgen Regulated lncRNA <i>NAALADL2-AS2</i> Promotes Tumor Cell Survival in Prostate Cancer
Levi Groen, Viktor Yurevych, Harshitha Ramu, et al.
Clinical Nuclear Medicine
|
November 23, 2017
223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice
Maarten J van der Doelen, Malou C P Kuppen, Marianne A Jonker, et al.
BMJ Open
|
May 19, 2021
Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the 'trials within cohorts' study ProBCI
Anke Richters, Richard P Meijer, Niven Mehra, et al.
Page
of 17